moneyheap
WTW · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is Willis Towers Watson Public Limited Company Ordinary Shares (WTW) stock moving?
WTW closed at $332.87 on Nov 10, up 1.8% from $327.01 on Nov 9, within a 30-day trading band of roughly $312 to $345. The Q3 report on Oct 29 came with the highest volume of the period (about 997K shares), and the Nov 2 session also traded about 1.0M shares. Since then, volume has steadily declined to 339K on Nov 10. The Nov 5 intraday high of $344.91 faded to a $336.51 close, so the upper end of the range has not held. The Q3 results were a slight beat, with revenue of $2.46B against a $2.455B estimate and adjusted EPS of $3.63 against $3.59. Analyst reactions were mixed. Several firms kept buy-type ratings (UBS Buy, Wells Fargo Overweight, Evercore ISI Outperform, KBW Outperform) and BMO and Morgan Stanley raised targets. Most others trimmed targets after the report, and KBW cut its target to $360 from $397 on Nov 10, the most recent move. Operational news was incremental: the Via Retirement launch, a defense and security leadership appointment, and a life sciences risk report. The Nov 3 8-K on the Principal Accounting Officer succession is routine, effective April 2027. Overall, the evidence supports a stable, mildly constructive view, but the falling volume and target cuts limit conviction.
News behind the analysis
- Keefe, Bruyette & Woods Adjusts Price Target on Willis Towers WatsonKBW lowered its price target on WTW to $360 from $397, after holding an Outperform rating in a Nov 5 note.
- Keefe, Bruyette & Woods Maintains Outperform on Willis Towers Watson, Raises Price Target to $397KBW kept its Outperform rating and raised its price target to $397 in a Nov 5 note.
- WTW Releases New Research on Economic Risks in the Life Sciences IndustryWTW's report names geopolitical tensions as the top economic risk for the life sciences sector.
- Morgan Stanley Adjusts Willis Towers Watson Price TargetMorgan Stanley raised its price target on WTW to $325 from $310.
- BMO Capital Adjusts Price Target on Willis Towers Watson Public to $362 From $332BMO Capital raised its price target on WTW to $362 from $332.
- UBS Maintains Buy on Willis Towers Watson, Lowers Price Target to $395UBS kept its Buy rating and trimmed its price target to $395 from $398.
- Wells Fargo Maintains Overweight on Willis Towers Watson, Lowers Price Target to $360Wells Fargo kept its Overweight rating and lowered its price target to $360.
- Evercore ISI Group Maintains Outperform on Willis Towers Watson, Lowers Price Target to $371Evercore ISI kept its Outperform rating and cut its price target to $371 after the Q3 report.
- WTW Reports Third Quarter 2026 Financial ResultsWTW reported Q3 2026 revenue of $2.46 billion and adjusted diluted EPS of $3.63.
- Willis Towers Watson Q3 Adj. EPS $3.63 Beats $3.59 Estimate, Sales $2.460B Beat $2.455B EstimateWTW's Q3 adjusted EPS of $3.63 and sales of $2.460B both narrowly beat consensus estimates.
About Willis Towers Watson Public Limited Company Ordinary Shares
WTW (Willis Towers Watson) is a global advisory, broking and solutions firm based in London and listed on Nasdaq. It is one of the largest insurance brokers in the world, and it also has a big HR and retirement consulting business that sets it apart from most rivals.
How it makes money
It earns fees and commissions, not insurance premiums, from two segments of roughly similar size. Health, Wealth & Career (about half of revenue) advises employers on benefits, pensions, pay and investments. Risk & Broking (the other half) places insurance and reinsurance for businesses and sells insurance consulting and software. Revenue was about $2.4–2.5 billion per quarter in 2026. The company is also making acquisitions, including Newfront and BMS Re's US reinsurance broking business, and running an AI-driven cost-savings plan called Propel.
What usually moves WTW
- Organic revenue growth
- Commercial insurance pricing cycle
- Employer benefits and pension consulting demand
- Operating margin expansion and cost savings
- Acquisitions and share buybacks